drugset / Trial / NCT01124175

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

NCT01124175

Phase 1 Completed 80 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of losartan 100 mg tablets (test) versus Cozaar® (reference), administered as 1 \* 100 mg tablet under fed conditions.

Timeline

Start
2003-10
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 100 mg

Indications

No indication recorded.